Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients

British Journal of Haematology

Volumn 116, Issue 4, 2002, Pages 803-811

  Buchheidt, Dieter ^a   Baust, Corinna ^a   Skladny, Heyko ^a   Baldus, Michael ^b   Bräuninger, Susanne ^c   Hehlmann, Rüdiger ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Bronchoalveolar lavage; Bronchoscopy; Invasive aspergillosis; Leukaemia; PCR

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; AUTOPSY; CLONOGENIC ASSAY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; LUNG INFILTRATE; LUNG LAVAGE; LUNG SURGERY; MAJOR CLINICAL STUDY; MYCOSIS; NEUTROPENIA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; DNA, FUNGAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; LUNG DISEASES, FUNGAL; LYMPHOMA; MALE; MIDDLE AGED; NEUTROPENIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036124787     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2002.03337.x     Document Type: Article

References (56)

1. Molecular typing by random amplification of polymorphic DNA and M13 southern hybridization of related paired isolates of Aspergillus fumigatus
2. Recommendations for diagnostic broncho-alveolar lavage
3. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus
4. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-90
5. Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction
6. Fungal infections in cancer patients: An international autopsy survey
7. Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus
8. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR
9. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis
10. Detection of Aspergillus species in blood and BAL samples of immunocompromised patients by two-step PCR: Clinical results
11. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
12. Autopsy-identified infections among bone marrow transplant recipients: A clinico-pathologic study of 56 patients
13. Infectious complications of patients undergoing therapy for acute leukemia: Current status and future prospects
14. Opportunistic fungal infection among cancer patients. A ten-year autopsy study
15. Invasive aspergillosis
16. Pulmonary fungal infections in immunocompromised patients: Incidence and risk factors
17. Detection and identification of fungal pathogens in blood by using molecular probes
18. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation
19. Detection of Aspergillus fumigatus PCR products by a microtitre plate based DNA hybridisation assay
20. Molecular epidemiology of nosocomial invasive aspergillosis
21. Trends in the postmortem epidemiology of invasive fungal infections at a University hospital
22. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates
23. Detection of aspergillus species DNA by PCR in bronchoalveolar lavage fluid
24. Prospective screening by a pan-fungal polymerase chain reaction assay in patients at risk for fungal infections: Implications for the management of febrile neutropenia
25. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening
26. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography
27. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
28. PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neu-tropenic patients
29. Universal fungus-specific primer systems and group-specific hybridization oligonucleotides for 18S rDNA
30. Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergil-losis
31. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with hae-matological malignancies
32. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis
33. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience
34. Screening for circulating galactomannan as a non-invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation
35. Specific detection of Aspergillus and Penicillium species from respiratory specimens by polymerase chain reaction (PCR)
36. General primer-mediated PCR for detection of Aspergillus species
37. The spectrum of non-Candida fungal infections following bone marrow transplantation
38. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
39. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients
40. Molecular epidemio-logical study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences
41. Non-value of Aspergillus antigen detection in bronchoalveolar lavage fluids of patients undergoing bone marrow transplantation
42. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis
43. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study
44. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR
45. Detection of Aspergillus fumigatus by polymerase chain reaction
46. The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid
47. Panfungal PCR assay for detection of fungal infection in human blood specimens
48. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies
49. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis
50. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
51. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi
52. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
53. The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia
54. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis
55. Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis
56. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study